Ironwood Pharmaceuticals

Listing Websites about Ironwood Pharmaceuticals

Filter Type:

Home - Ironwood Pharmaceuticals

(7 days ago) Home - Ironwood Pharmaceuticals Ironwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseases Media Releases May 25, 2022 Ironwood Presents New Data Demonstrating Potential of IW-3300 for Visceral Pain at Digestive Disease Week® (DDW) 2022 May 9, 2022

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Our Product - Ironwood Pharmaceuticals

(6 days ago) Linzess® (linaclotide) capsules for oral use Please see full LINZESS Prescribing Information below and a website dedicated to providing you with product-specific information. In order to monitor the safety of our product, we encourage reporting any side effects experienced while taking LINZESS to AbbVie at …

Url: Visit Now

Category:  Health Detail Drugs


Ironwood Pharmaceuticals - Wikipedia

(4 days ago) Microbia changed its name to Ironwood in 2008 and shortened the name of the industrial business to Microbia. By 2009, Ironwood had raised a total of $281M. In early 2010 Ironwood held its IPO, which priced at $11.25 a share, below the target price of $14. Later that year it sold its interests in Microbia to DSM for an undisclosed sum.

Url: Visit Now

Category:  Health Detail Drugs


Ironwood Pharmaceuticals, Inc. - Financial Information - Quarterly …

(8 days ago) Ironwood Pharmaceuticals, Inc. - Financial Information - Quarterly Results. NASDAQ: IRWD 12.18+0.40 3.40% Volume: 3,335,787 April 22, 2022 4:00 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals LinkedIn

(7 days ago) Pharmaceutical Manufacturing Company size 201-500 employees Headquarters Boston, MA Type Public Company Founded 1998 Locations Primary 100 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals - Crunchbase Company Profile & Funding

(4 days ago) Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc.,

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals (IRWD) - Forbes

(8 days ago) Ironwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. IndustryPharmaceuticals, Biotechnology & Life Sciences Country/Territory …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. Company Profile Boston, MA

(2 days ago) Company Description: Ironwood Pharmaceuticals takes a stand against gastrointestinal ailments and other medical conditions.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Organization Ironwood Pharmaceuticals

(3 days ago) Ironwood Pharmaceuticals Report issue Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4 Founded: Cambridge MA United States (1998) Organization Overview First Clinical Trial 2006 NCT00258193 First Marketed Drug 2015 lesinurad (zurampic) First NDA Approval None Last Known Activity 2019 Timeline Acquisitions Trial Sponsor

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, News, Quote

(6 days ago) BOSTON, May 09, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the company and its collaborators will present eight studies, including

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals Inc. Cl A - MarketWatch

(8 days ago) Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Working at Ironwood Pharmaceuticals Glassdoor

(2 days ago) Ironwood Pharmaceuticals Interviews Experience Positive 50% Negative 21% Neutral 29% Getting an Interview Applied online 42% Recruiter 26% Employee Referral 21% Difficulty 3.3 Average Hard Average Easy Dec 27, 2021 Senior Data Analyst Interview Anonymous Employee in Boston, MA No Offer Positive Experience Average Interview Application

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc. (IRWD): Lucky investors are lined …

(4 days ago) Presently, Ironwood Pharmaceuticals Inc. shares are logging -19.97% during the 52-week period from high price, and 12.73% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Stock Forecast, Price & News

(6 days ago) Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) posted its quarterly earnings results on Thursday, May, 5th. The biotechnology company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.27 by $0.06. The biotechnology company earned $97.53 million during the quarter, compared to analyst estimates of $96.62 million.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals - IRWD - Stock Price & News The …

(9 days ago) Ironwood Pharmaceuticals Inc. is an entrepreneurial pharmaceutical company that discovers develops and intends to commercialize differentiated medicines that improve patients’ lives. Interactive

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Marla L.

(7 days ago) Ironwood Pharmaceuticals, Inc. has a 52-week low of $10.13 and a 52-week high of $14.27. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price Today, Quote …

(6 days ago) A high-level overview of Ironwood Pharmaceuticals, Inc. (IRWD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Exploring Growth Opportunities In Ironwood Pharmaceuticals Inc.

(3 days ago) According to the data, the short interest in Ironwood Pharmaceuticals Inc. (IRWD) stood at 10.55% of shares outstanding as of Apr 28, 2022; the number of short shares registered in Mar 30, 2022 reached 16.05 million. The stock has fallen by -3.95% since the beginning of the year, thereby showing the potential of a further growth.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc Class A - Stock Quote IRWD

(Just Now) Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Latest Stock News

(1 days ago) Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 misses by $0.07, revenue of $117.13M beats by $6.96M SA News Thu, Feb. 17 Ironwood Pharmaceuticals Q4 …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Grants Management System - Ironwood Pharma

(4 days ago) Welcome to the Ironwood Grants Management System. Ironwood believes that it is important to give back to the communities in which we work and have a corporate presence. We routinely support non-profit service, medical education, and patient advocacy organizations whose primary focus is: (b) On improving healthcare in communities, increasing

Url: Visit Now

Category:  Health Detail Drugs


Ironwood Expands Pipeline with Option Agreement to - Global …

(8 days ago) after a troubled past couple of years, stopping development of some programs and trimming r&d, ironwood pharmaceuticals is moving forward and expanding its pipeline by entering into a collaboration and license option agreement with cour pharmaceutical development, a company developing novel immune-modifying nanoparticles to treat autoimmune …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc - Reuters

(8 days ago) Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company that is focused on the development and commercialization of GI …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: …

(3 days ago) In this article: Wall Street expects a year-over-year increase in earnings on higher revenues when Ironwood Pharmaceuticals (IRWD) reports …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


IRONWOOD PHARMACEUTICALS, INC. : IRWD Stock Price

(6 days ago) Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company that is focused on the development and commercialization of GI products in areas of unmet need, including irritable bowel syndrome with constipation (IBS C), and chronic idiopathic constipation (CIC).

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals Jobs and Careers Indeed.com

(6 days ago) 12 Ironwood Pharmaceuticals jobs. Apply to the latest jobs near you. Learn about salary, employee reviews, interviews, benefits, and work-life balance

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


143 Salaries at Ironwood Pharmaceuticals Shared by Employees

(8 days ago) The average Ironwood Pharmaceuticals salary ranges from approximately $131,239 per year for a Clinical Sales Specialist to $222,783 per year for a Director. Ironwood Pharmaceuticals employees rate the overall compensation and benefits package 4.2/5 stars.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Cafepharma Message Boards Pharma …

(Just Now) Ironwood Pharmaceuticals Cafepharma Message Boards Pharma Sales, Device Sales, Lab Sales. Forums > Pharma/Biotech Companies >. Merck and Seagen meeting this week on possible acquisition — Sanofi and GSK tout 72% Omicron efficiency in Phase III trial of next-gen shot — PwC says pharma M&A is down, but more expected in second half of year

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals (NasdaqGS:IRWD) - Simply Wall St

(2 days ago) Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as …

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


IRWD Stock News Today Why did Ironwood Pharmaceuticals …

(1 days ago) Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call Transcript seekingalpha.com - May 8 at 8:03 AM: Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues finance.yahoo.com - May 6 at 1:14 PM: Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Is Ironwood Pharmaceuticals Stock a Buy? The Motley Fool

(6 days ago) For many pharmaceutical stocks, there's likely one product that's driving the company's growth. With Ironwood, it's Linzess. The drug treats people who have irritable bowel syndrome with

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Insider Sell: Ironwood Pharmaceuticals MarketScreener

(8 days ago) All news about IRONWOOD PHARMACEUTICALS, INC. 06/06: Keurig Dr Pepper, ON Semiconductor Rise Monday After S&P Dow Jones Announces Index Resh.. MT. 06/03: IRONWOOD PHARMACEUTICALS INC: Submission of Matters to a Vote of Security Holders (form 8.. AQ. 06/03:

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Recent Change of -2.06% in the Ironwood Pharmaceuticals Inc.

(8 days ago) Ironwood Pharmaceuticals Inc. (IRWD) full year performance was -5.55%. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Ironwood Pharmaceuticals Inc. shares are logging -20.04% during the 52-week period from high price

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


IRWD Ironwood Pharmaceuticals Inc. Cl A Stock Overview (U

(7 days ago) Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need

Url: Visit Now

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals: Jobs LinkedIn

(2 days ago) Ironwood Pharmaceuticals Pharmaceutical Manufacturing Boston, MA 26,207 followers Ironwood is on a mission to advance treatment of gastrointestinal diseases & redefine the standard of care for

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, inc (IRWD) Q2 2021 Earnings Call …

(1 days ago) Ironwood, along with AbbVie, entered into a settlement agreement with Teva Pharmaceuticals, providing a license to Teva for it's generic version of the 72 mcg LINZESS in the U.S. beginning March

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Explore your future in medical, safety and regulatory affairs

(4 days ago) At Ironwood Pharmaceuticals, we are committed to advancing the treatment of GI diseases and redefining the standard of care for millions of GI patients. Ironwood is more than just a company—it’s a group of people, each with unique perspectives and talents, who come together to create medicines designated to improve the lives of GI patients.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs